Belmont, MA, United States of America

Alexander K Andrainov

This inventor holds 1 USPTO granted patent. Top assignee: Avant Immunotherapeutics, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander K Andrainov. Retrieved from https://idiyas.com/inventor/alexander-k-andrainov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander K Andrainov: Innovator in Immunoadjuvants

Introduction

Alexander K Andrainov is a notable inventor based in Belmont, Massachusetts. He has made significant contributions to the field of immunology through his innovative work on immunoadjuvants. His research focuses on enhancing immune responses, which is crucial for developing effective vaccines and therapies.

Latest Patents

Alexander K Andrainov holds one patent related to immunoadjuvants. This patent provides immunogenic compositions and methods for inducing enhanced immune responses using an antigen combined with a water-soluble polymer and an amphiphilic compound. This invention has the potential to improve vaccine efficacy and therapeutic outcomes.

Career Highlights

Andrainov is associated with Avant Immunotherapeutics, Inc., where he applies his expertise in immunology to advance the company's research and development efforts. His work is instrumental in the pursuit of innovative solutions in the field of immunotherapy.

Collaborations

He has collaborated with notable colleagues, including Jean R Loebelenz and Bryan E Roberts, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Alexander K Andrainov's contributions to immunology through his patent on immunoadjuvants highlight his role as a key innovator in the field. His work continues to influence the development of enhanced immune response strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…